Albert Seymour - 23 Feb 2023 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Role
President and Chief Executive Officer, Director
Signature
/s/ Paul Alloway, Attorney-in-Fact for Albert Seymour
Issuer symbol
QTTB
Transactions as of
23 Feb 2023
Net transactions value
$0
Form type
4
Filing time
27 Feb 2023, 15:05:18 UTC
Previous filing
20 Jan 2023
Next filing
08 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Employee Stock Option (Right to Buy) Award $0 +632,000 $0.000000 632,000 23 Feb 2023 Common Stock 632,000 $1.60 Direct F1
transaction FIXX Restricted Stock Units Award $0 +105,000 $0.000000 105,000 23 Feb 2023 Common Stock 105,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2023.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F3 The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026.

Remarks:

President and Chief Executive Officer